The Effect of Augmented Reality Based Training on Preeclampsia Case (preeclamside)

December 8, 2024 updated by: Simge Ozturk, Inonu University

The Effect of Augmented Reality Based Training on Preeclampsia Case on Nursing Students' Diagnosis and Intervention Planning Skills

However, no study has been found in the care of preeclampsia, which is highly effective on maternal and fetal health. Therefore, this study was planned to determine the effect of augmented reality-based training on the diagnosis and intervention planning skills of nursing students.

Study Overview

Detailed Description

Although pregnancy is a physiological process in women's lives, many women lose their lives due to the lack of timely and appropriate treatment of the complications it brings with it. According to the World Health Organization 2024 report, approximately 800 women die every day due to preventable causes related to pregnancy and childbirth. Preeclampsia, which is among the hypertensive diseases of pregnancy, is a complication of pregnancy and ranks among the top three causes of maternal mortality worldwide. Preeclampsia is defined as hypertension that develops after the 20th week of pregnancy and is accompanied by proteinuria/thrombocytopenia, renal failure, liver dysfunction, and cerebral/visual symptoms.

Considering the risks of preeclampsia complications, taking precautions before the onset of complications and treating complications with appropriate methods are extremely important in reducing the mortality rates of both pregnant and fetus. In order to maintain safe patient care and the health of individuals, nurses should know what kind of nursing care should be applied in the antenatal period to diagnose, evaluate and prevent complications of preeclampsia. In the literature, it is recommended that nursing care for preeclampsia patients should include the diagnoses of infection risk, disruption in sleep pattern, acute pain, constipation, impaired physical movement, lack of self-care, and fatigue. Nursing care should include individualized, holistic, systematic, high quality, feasible, applicable, sustainable care methods including technological methods, models and theories for all pregnant women with more than 2 of the risks of preeclampsia by ACOG.

Technological methods, which have been frequently used in the health system in recent years, are used because they are cheap, usable, accelerate the decision-making process, and reduce workload. Virtual reality (VR) applications are technological applications that create a reality environment with the help of scenarios and facilitate learning complex cases and diseases by increasing students' knowledge and skills. In addition, this method allows students to develop critical thinking skills, participate in clinical decision-making processes and receive feedback. In the literature, VR application has been used in triage patients and nursing care of pediatric patients. However, no study has been found in the care of preeclampsia, which is highly effective on maternal and fetal health. Therefore, this study was planned to determine the effect of augmented reality-based training on the diagnosis and intervention planning skills of nursing students.

Study Type

Interventional

Enrollment (Estimated)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Malatya, Turkey, 44200
        • Inonu University
        • Contact:
        • Sub-Investigator:
          • sermin timur taşhan, Ph.D
        • Sub-Investigator:
          • emine özbek, Rsc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Continuing the course of Women's Health and Diseases Nursing,

    • Volunteering to participate in the research,
    • No physical or psychological health problems preventing the completion of the research forms.

Exclusion Criteria:

  • - Not watching the whole case given with virtual glasses,
  • Failure to attend class during the week of the preeclampsia lecture in the course syllabus.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental group
An appointment will be made to meet with the students in the experimental group in a suitable classroom of the school. After the pre-test data, the students in the experimental group will be shown the preeclampsia case with virtual glasses for about 5-10 minutes. Then the post-test will be applied. A scenario including preeclampsia case and nursing care practices will be created in the virtual reality environment, and 10 experts will be consulted about the scenario before the students are shown it. This application will not have any side effects.
An appointment will be made to meet with the students in the experimental group in a suitable classroom of the school. After the pre-test data, the students in the experimental group will be shown the preeclampsia case with virtual glasses for about 5-10 minutes. Then the post-test will be applied. A scenario including preeclampsia case and nursing care practices will be created in the virtual reality environment, and 10 experts will be consulted about the scenario before the students are shown it. This application will not have any side effects.
Other: control group
After the pre-test data, the preeclampsia case will be explained to the students in the control group with the classical lecture method in the Women's Health and Diseases Nursing course and the post-test will be applied.
After the pre-test data, the preeclampsia case will be explained to the students in the control group with the classical lecture method in the Women's Health and Diseases Nursing course and the post-test will be applied.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preeclampsia Nursing Care Plan
Time Frame: one month
he nursing care plan consists of 4 open-ended questions including nursing diagnosis, risks, interventions and evaluation. Students will receive 3 points for each correct diagnosis. If they write all of the diagnoses, they will receive a total of 48 points from the diagnoses. If they correctly write 2 of the risk factors related to the diagnosis of preeclampsia added to the diagnoses for each diagnosis, they will receive 1 point from each diagnosis. They will receive a maximum of 16 points from risks. If they write at least 5 nursing interventions for each diagnosis, they will receive 2 points for each diagnosis. A maximum of 32 points will be obtained from interventions. The evaluation part will be 0.25 points. If they write the evaluations of all diagnoses correctly, they will receive 4 points. A total of 100 points can be obtained from the nursing care plan, with a minimum of 0 and a maximum of 48+16+32+32+4.
one month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant Information Form
Time Frame: one month
The information form, which was created by utilizing the literature, consists of a total of 10 questions (student's name, surname, telephone number, student number, age, gender, pre-preparation information, etc.).
one month
Preeclampsia Knowledge Test
Time Frame: one month
The preeclampsia information form (preeclampsia symptoms, ric factors, laboratory findings of preeclampsia, etc.) created by the researchers in line with the literature consists of a total of 10 questions. Each question is evaluated as 1 point and a minimum score of 0 and a maximum score of 10 can be obtained from the test. Before finalizing the information form, the opinions of 10 experts will be taken to determine its suitability.
one month
Presence Scale
Time Frame: one month
The Turkish validity and reliability study of the scale developed by Witmer et al. (2005) was conducted by Gökoğlu and Çakıroğlu (2019). Consisting of 29 items, the five-point Likert-type scale has five sub-dimensions: Engagement, Adaptation/Environmentalization, Sensory Engagement, Interaction, and Interface Quality. High scores obtained from the scale indicate that presence is effective.
one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 20, 2024

Primary Completion (Estimated)

February 20, 2025

Study Completion (Estimated)

August 20, 2025

Study Registration Dates

First Submitted

December 8, 2024

First Submitted That Met QC Criteria

December 8, 2024

First Posted (Estimated)

December 12, 2024

Study Record Updates

Last Update Posted (Estimated)

December 12, 2024

Last Update Submitted That Met QC Criteria

December 8, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Experimental Group

Subscribe